Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
J Clin Pathol ; 45(9): 796-8, 1992 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-1401210

RESUMO

AIMS: To evaluate the effect of 10 day triple treatment on H pylori eradication and associated gastritis. METHODS: Fifty patients with H pylori positive non-ulcer dyspepsia were treated for 10 days with amoxicillin, tinidazole, and bismuth salts. Histological examination of the antral mucosa was performed before (T0), six weeks (T1), and six months (T2) after treatment. The new Sydney classification of gastritis was used, using a score from 0 to 3 to grade degree of inflammation, atrophy, activity (intraepithelial or lamina propria damage) and H pylori. RESULTS: At T0 all patients had chronic active gastritis. Lymphoid follicules were present in 12 cases. At T1 33 patients were H pylori negative: the score showed a decrease of activity (from 2.5 to 0.54). The result was confirmed at T2 (mean score 0.22). Inflammation decreased from 1.8 to 1.4 at T2. Only one case of follicular gastritis was observed. In H pylori positive patients the scores did not show significant modifications. CONCLUSIONS: Ten day triple treatment is effective in eradicating H pylori in 69% of cases, causing a decrease of the total score for gastritis. Activity, defined by polymorph infiltration, was promptly reduced when H pylori was eradicated. There was a trend to a reduction in inflammation, but atrophy was irreversible.


Assuntos
Mucosa Gástrica/patologia , Gastrite/patologia , Infecções por Helicobacter/patologia , Helicobacter pylori , Amoxicilina/uso terapêutico , Bismuto/uso terapêutico , Doença Crônica , Quimioterapia Combinada , Gastrite/tratamento farmacológico , Gastroscopia , Infecções por Helicobacter/tratamento farmacológico , Humanos , Pessoa de Meia-Idade , Tinidazol/uso terapêutico
2.
Panminerva Med ; 36(3): 149-51, 1994 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7877830

RESUMO

The existence of the so called "Villus Size Gradient" (VSG) which defines the proportional decrease in height of intestinal villi from duodenum to ileum is well documented in adult animals and man. The aim of this study is to define whether the VSG is present since birth or, if not, when and why it appears. We have measured the height of intestinal villi in 25 rats: 5 at 1 day from birth, 5 at 5 days, 5 at 8 days, 5 at 15 days and 5 at 30 days. We have prepared histological slides of a duodenal, jejunal and ileal tract of each animal and measured the height of villi on microphotographs. At day 1 we observed a higher size of duodenal villi statistically significant with respect to jejunum and ileum, while at day 5 no differences were observed between the various intestinal tracts. The VSG become evident 8 days after birth progressively increasing to day 30. The predominance of duodenum present at birth is therefore probably due to the fetal developmental growth which is known to be more precocious in duodenum than in more distal tracts. Five days after birth the intestinal villi are equally developed, while in later ages the VSG appears. So we can conclude that the VSG is a consequence of luminal and humoral factors and not a predetermined event.


Assuntos
Mucosa Intestinal/crescimento & desenvolvimento , Análise de Variância , Animais , Mucosa Intestinal/ultraestrutura , Ratos , Ratos Endogâmicos
3.
Minerva Med ; 79(7): 579-81, 1988 Jul.
Artigo em Italiano | MEDLINE | ID: mdl-3405461

RESUMO

A previously healthy 62 years old man was admitted for weight loss, weakness and pigmentation of skin with increased tumor markers and altered hepatic tests. The final diagnosis was Systemic Lupus Erythematosus, despite clinical appearance. High doses of glucocorticoids were used and a sudden improving of the disease was obtained.


Assuntos
Biomarcadores Tumorais/metabolismo , Hepatopatias/etiologia , Lúpus Eritematoso Sistêmico/complicações , Transtornos da Pigmentação/etiologia , Humanos , Lúpus Eritematoso Sistêmico/metabolismo , Masculino , Pessoa de Meia-Idade
4.
Recenti Prog Med ; 81(5): 351-5, 1990 May.
Artigo em Italiano | MEDLINE | ID: mdl-2198647

RESUMO

The liver plays a dominant role in the metabolism of the thyroidal hormones; it is here that the 5' deiodase acts to convert part of T4 to T3. There are eight further circulating iodothyronines: the rT3, mainly derived from T4, appears to be the major inhibitor of T4 and T3. Thus, if rT3 increases, the metabolic effects of T3 and T4 can be quite different. In the course of some chronic systemic diseases (e.g. hepatic cirrhosis) rT3 increases simultaneously with the decrease of T3 levels. Therefore we can describe particular alterations of the thyroidal pattern typical of chronic liver diseases: low T3 syndrome, low T3 and T4 syndrome, high T4 syndrome, mixed forms. T3 and T4 diminish due to inefficient hepatic deiodination and defective hepatocellular uptake. Inefficient hepatic deiodination and defective hepatocellular uptake. T4 levels decrease, most likely because of an inefficient production of thyroid binding globulin, or the action of a peripheral binding inhibitor. During acute liver diseases and primitive biliary cirrhosis, we can observe an increase of T4 and TBG together with an increase of the acute phase proteins. Such complex hormonal mechanisms are not influenced by TSH, which appears normal or inhibited, as the TRH stimulus test is normal. The explication can be found in an enhanced conversion of T4 to T3 in the pituitary gland. The biological and clinical significance of these mechanisms might be that of creating a "protective" state for an organism in a catabolic state by reducing the circulating T3. A relationship has been found between circulating thyroidal hormones levels, particularly the T3, rT3 and rT3/T3 ratio, and the state of hepatic functional insufficiency.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Hepatopatias/fisiopatologia , Fígado/fisiologia , Glândula Tireoide/fisiopatologia , Hormônios Tireóideos/fisiologia , Homeostase/fisiologia , Humanos , Fígado/metabolismo , Hepatopatias/metabolismo , Hormônios Tireóideos/sangue
7.
Minerva Anestesiol ; 71(5): 181-95, 2005 May.
Artigo em Inglês, Italiano | MEDLINE | ID: mdl-15834347

RESUMO

E-learning is a new project for education based on the adoption of new computerised, multimedia and telematic technologies. Its application has deeply changed the concept of a teacher-based teaching to a student-centred educational project. It offers a great flexibility in the educational methodology, in the administration of contents, in the synchronous and/or asynchronous interaction between teachers and students, in the organisation and in the structure of the course, in the educational plans, in the support, the tracking and the evaluation of the student. E-learning could represent a great resource and a possible revolution in the concept of education and in the field of medical education as well. In some specific fields of application, as Emergency and Disaster Medicine, where the interaction between the student, the teacher and the patient, even if of great importance, are difficult to obtain in a quiet setting and have a lot of organizing, technical and economic troubles, e-learning approach could find a fertile field of application. In this paper we present a new program of educational activities we started in the field of Emergency and Disaster Medicine together with a review of the history of the instructional design and related technologies, ranging from the development of computer aided instruction to modern e-learning applications as teaching methodologies, and their impact on pedagogic and operative aspects.


Assuntos
Instrução por Computador , Desastres , Medicina de Emergência/educação , Humanos
8.
South Med J ; 76(6): 796-8, 1983 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-6304917

RESUMO

We present two cases of fibrolamellar carcinoma. Because of its usual presentation as a solitary mass in the noncirrhotic liver of a young girl, this tumor is likely to be mistaken clinically for a benign lesion. Its microscopic appearance is unique and easily separated from other types of hepatocellular carcinoma, an important distinction because of the better prognosis of fibrolamellar carcinoma.


Assuntos
Carcinoma Hepatocelular/diagnóstico , Carcinoma/diagnóstico , Neoplasias Hepáticas/diagnóstico , Adolescente , Carcinoma/patologia , Carcinoma/cirurgia , Diagnóstico Diferencial , Eosinófilos/patologia , Feminino , Humanos , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/cirurgia , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/cirurgia , Prognóstico , Reoperação
9.
J Nucl Med Allied Sci ; 33(3 Suppl): 89-93, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2480432

RESUMO

In order to evaluate the behaviour of alpha-fetoprotein (AFP) and Tissue Polypeptide Antigen (TPA) in non neoplastic chronic hepatic diseases 60 patients suffering from chronic hepatitis have been studied, 28 of them with different ethiology cirrhosis, 4 with primary biliary cirrhosis (CBP), 18 with chronic active hepatitis (ECA), 5 with chronic persistent hepatitis (ECP), 3 suffering from alcoholic and 2 drug-induced hepatitis. In each case the diagnosis was biopsy-proved. We have found that TPA clearly shows an increase in about 90% of cirrhosis and in about 50% of ECA. Moreover, the group with non-A, non-B (NANB) cirrhosis and chronic hepatitis has shown a statistically significant correlation between TPA and alanine aminotransferase (ALT). On the other hand, AFP hants' shown statistically significant variations. The reasons of the TPA increase must probably be looked for in the marked sensitivity of this protein to non neoplastic tissues in rapid regeneration, in addition to the sensitivity to neoplastic tissues. Further studies will be carried out to evaluate the usefulness of TPA to tracing possible cytolitic relapses or any resumption of activity in hepatic cirrhosis.


Assuntos
Hepatopatias/metabolismo , Peptídeos/análise , alfa-Fetoproteínas/análise , Adulto , Idoso , Doença Crônica , Feminino , Hepatite/imunologia , Hepatite/metabolismo , Humanos , Cirrose Hepática/imunologia , Cirrose Hepática/metabolismo , Hepatopatias/imunologia , Masculino , Pessoa de Meia-Idade , Antígeno Polipeptídico Tecidual
10.
Ital J Gastroenterol ; 23(4): 202-7, 1991 May.
Artigo em Inglês | MEDLINE | ID: mdl-1751815

RESUMO

Morphofunctional alterations to the intestinal mucosa are influenced by three main factors: food, bilio-pancreatic secretions, intestinal hormones. In order to assess the importance of each one, histological and histochemical tests were performed on different segments of intestine taken from rats which were sacrificed one month after the following procedure: gastrojejunal anastomosis on a Roux loop (Model I); same procedure plus biliopancreatic bypass into the jejunum (Model II). When compared to the controls, Model I duodenum samples revealed hypertrophy of the entire wall with "bundles" of villi, while Model II samples showed a clear hypotrophy and reduction in the number of duodenal villi. To such modifications of the duodenum correspond longer, thinner villi in the other bowel segments, particularly in the jejunum and distal ileum. These results suggest that the predominant trophic effect derives from contact with biliopancreatic secretions at a proximal level. The modifications of the duodenal mucosa appear to regulate the trophism of the distal segments probably by the secretion of distant acting enterohormones.


Assuntos
Adaptação Fisiológica/fisiologia , Desvio Biliopancreático/efeitos adversos , Mucosa Intestinal/patologia , Jejuno/cirurgia , Estômago/cirurgia , Anastomose em-Y de Roux/efeitos adversos , Anastomose Cirúrgica/efeitos adversos , Animais , Ductos Biliares/cirurgia , Duodeno/patologia , Íleo/patologia , Mucosa Intestinal/metabolismo , Jejuno/patologia , Modelos Biológicos , Ductos Pancreáticos/cirurgia , Ratos , Ratos Endogâmicos
11.
South Med J ; 78(2): 130-3, 1985 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-3975707

RESUMO

A significant percentage of children who are fecally incontinent are so from improper operation or failure to recognize a surgically correctable problem. Over the past five years, we have managed ten children who had operations for anorectal problems and two with anterior anus. Seven were seen after poorly positioned pull-through procedures for imperforate anus and had anal repositioning, four successfully. Gracilis sling was successful in two of the other three. In two children overflow after a Duhamel operation for Hirschsprung's disease was corrected by division of a persistent anorectal septum. The third child with a disrupted Duhamel procedure was cured by anolevatorplasty. In two children an anterior ectopic anus was made continent by posterior anoplasty. Primary and secondary deviations from proper anatomy of the anorectal region will result in incontinence, which may be recognized by physical examination and defecograms. Proper operation usually produces acceptable continence.


Assuntos
Incontinência Fecal/cirurgia , Adolescente , Canal Anal/cirurgia , Anus Imperfurado/complicações , Anus Imperfurado/cirurgia , Criança , Pré-Escolar , Incontinência Fecal/etiologia , Feminino , Doença de Hirschsprung/cirurgia , Humanos , Masculino , Complicações Pós-Operatórias
12.
J Trauma ; 22(12): 1019-20, 1982 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7143508

RESUMO

Myocardial performance is severely depressed following burns to more than 30% of the body surface area. Cardiac output in the immediate postburn period is dissociated from plasma volume. Many attempts have been made to improve early postburn hemodynamics with little success. Continuous infusion dopamine in low doses has recently been reported to improve at least one index of cardiac performance (LVSWI). We report the use of low-dose (5-10 mcg/kg X min) dopamine in the first 24 hours postburn in 20 seriously burned adults. Hemodynamic data are presented immediately preinfusion and after 1 hour of dopamine. Low-dose dopamine produced no change in cardiac index, arterial pressure, LVSWI, or any other hemodynamic parameter. We conclude that dopamine is of no benefit in treating the depressed myocardial function seen following major burns.


Assuntos
Queimaduras/complicações , Baixo Débito Cardíaco/tratamento farmacológico , Dopamina/uso terapêutico , Adulto , Baixo Débito Cardíaco/etiologia , Dopamina/administração & dosagem , Humanos
13.
J Hepatol ; 11(3): 339-43, 1990 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-2127054

RESUMO

One hundred and fifteen patients with chronic type B, D and non-A, non-B hepatitis treated with recombinant alpha-interferon were tested for six different autoantibodies prior to or during therapy, and the course of treatment was compared in autoantibody-positive and -negative patients. Three out of 25 (12%) hepatitis B patients, 14 out of 30 (47%) hepatitis D patients and 19 out of 60 (32%) chronic non-A, non-B hepatitis carriers had baseline or post-therapy autoantibodies. The rate of response between patients with and without autoantibodies among B, D and non-A, non-B patients was, respectively, 67 vs. 79%, 23 vs. 25%, 70 vs. 61% (p = N.S.). No adverse reaction was observed in the 36 patients who had or developed nuclear, smooth muscle, parietal cells and thyroid autoantibodies during therapy. A patient with baseline antibodies against liver and kidney microsomes developed an icteric acute hepatitis at the fourth month of therapy, but five other patients with this reactivity responded to therapy uneventfully. The presence of autoantibodies before therapy or their induction following therapy is not a contraindication to the use of interferon in patients with chronic viral hepatitis.


Assuntos
Autoanticorpos/imunologia , Hepatite Viral Humana/tratamento farmacológico , Interferon Tipo I/uso terapêutico , Animais , Doença Crônica , Imunofluorescência , Hepatite B/tratamento farmacológico , Hepatite B/epidemiologia , Hepatite B/imunologia , Hepatite C/tratamento farmacológico , Hepatite C/epidemiologia , Hepatite C/imunologia , Hepatite D/tratamento farmacológico , Hepatite D/epidemiologia , Hepatite D/imunologia , Hepatite Viral Humana/epidemiologia , Hepatite Viral Humana/imunologia , Humanos , Interferon Tipo I/imunologia , Itália/epidemiologia , Camundongos , Estudos Prospectivos , Ratos
14.
J Hepatol ; 11 Suppl 1: S43-9, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2127787

RESUMO

Eighty patients with chronic non-A, non-B hepatitis completed a randomized controlled trial of the therapeutic efficacy of recombinant interferon alfa-2b. Twenty-nine received 1 million units and 26 received 3 million units of interferon subcutaneously thrice weekly for 6 months, and 25 were controls. Normalization or a significant decrease of alanine aminotransferase values was obtained in 19/29 (66%) patients treated with 1 million units, in 18/26 (69%) patients treated with 3 million units and in one control patient (4%, p less than 0.05). However, when control patients were randomized after the initial 24 weeks to receive 1 or 3 million units of interferon for 48 weeks, 12/14 (86%) patients receiving 3 million units responded to therapy versus 3/11 patients receiving 1 million units (27%, p less than 0.05). After a 1 to 6 months follow-up period post treatment, an alanine aminotransferase relapse was observed in 18/30 (60%) responders to 3 million units and in 17/22 (77%) responders to 1 million units. Cirrhotic patients responded less than patients with non-cirrhotic disease (47 vs. 78%, p less than 0.05). Only responders treated with 3 million units significantly ameliorated their histologic picture (pre-therapy Knodell's index = 8.9, post-therapy = 6.0, p less than 0.05). The data confirm that treatment with interferon is of benefit in patients with chronic non-A, non-B hepatitis.


Assuntos
Hepatite C/terapia , Interferon-alfa/uso terapêutico , Adulto , Alanina Transaminase/sangue , Doença Crônica , Feminino , Hepatite C/sangue , Hepatite C/patologia , Humanos , Interferon alfa-2 , Masculino , Pessoa de Meia-Idade , Proteínas Recombinantes
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa